Revelstoke Capital Partners has announced a significant growth investment in MediQuant, LLC, representing the seventh investment from Revelstoke Capital Partners Fund III.
MediQuant provides hospital data active archiving and interoperability solutions for hospitals and health systems. MediQuant’s flagship product, DataArk®, allows health systems to maintain access to relevant clinical, financial and administrative data, ensuring that valuable data required for patient care and compliance is secure and within reach. MediQuant’s platform applications provide an active view of patient records from within existing systems. This allows customers to reduce security risks and costs by eliminating redundant software applications. MediQuant has successfully rationalized more than 3,300 clinical, financial and administrative applications since inception.
Revelstoke Capital Partners is a private equity firm specializing in the healthcare and business services sectors. Revelstoke is based in Denver and has approximately $5.1 billion of assets under management. Since the firm’s inception in 2013, Revelstoke has completed 191 acquisitions, which include 28 platform companies and 163 add-on acquisitions.
MediQuant was advised by Harris Williams and Ropes & Gray LLP. Revelstoke was advised by OM Partners, LLC and McGuireWoods LLP. Terms of the transaction were not disclosed.
According to data captured in the LevinPro HC database, this acquisition represents the 169th eHealth transaction of 2024, and the ninth in the electronic health record (EHR) specialty. There were 16 EHR deals announced during 2023, and 20 announced during 2022.
